Microbial Lipid Membrane and Biofilm

Lipid membranes and biofilms are fundamental structural components of microbial life that serve as major targets for antimicrobial therapy. The microbial lipid membrane provides a selective barrier and structural integrity, with specific components like lipopolysaccharides in bacteria or ergosterol in fungi offering targets for specialized antibiotics and antifungals (Clinical Microbiology Reviews, 2017). Biofilms are complex, multicellular communities of microorganisms embedded within a self-produced matrix of extracellular polymeric substances (EPS), including proteins, DNA, and polysaccharides (Nature Reviews Microbiology, 2004). This matrix acts as a physical and chemical shield, significantly increasing resistance to host immune responses and conventional antimicrobial agents (Frontiers in Microbiology, 2020). Therapeutic strategies involve the use of membrane-disrupting agents that cause depolarization or pore formation, such as daptomycin or polymyxins, as well as biofilm-disrupting enzymes like dornase alfa designed to degrade the protective matrix (Journal of Antimicrobial Chemotherapy, 2003). Understanding these targets is crucial for developing treatments against persistent and multi-drug resistant infections.

Other names

Bacterial membraneFungal membraneExtracellular polymeric substance (EPS) matrixMicrobial biofilmMicrobial cell envelope

Drugs targeting these structures typically act through physical disruption of the lipid bilayer, leading to pore formation and cytoplasmic leakage, or by degrading the extracellular polymeric matrix of biofilms to restore antibiotic sensitivity (Nature Reviews Drug Discovery, 2013).